Research study Program year 2023 Source: CMS Open Payments

A Proof of Concept Study to Evaluate the Efficacy, Safety and Tolerability of Secukinumab 300 MG Over 32 Weeks in Adult Patients With Biopsy-Proven Forms of Lichen Planus Not Adequately Controlled With Topical Therapies - Prelude

Research payments

$4,360,760

49 payments

Through program year 2023, $4,360,760 in research payments was reported against A Proof of Concept Study to Evaluate the Efficacy, Safety and Tolerability of Secukinumab 300 MG Over 32 Weeks in Adult Patients With Biopsy-Proven Forms of Lichen Planus Not Adequately Controlled With Topical Therapies - Prelude, across 49 payments, paid by Novartis Pharmaceuticals Corporation.

Paid by: Novartis Pharmaceuticals Corporation
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$33,350	3
2022	Research	$125,329	15
2021	Research	$3,434,132	17
2020	Research	$767,948	14

Breakdown

Who paid Research payments · program years 2020–2023

Novartis Pharmaceuticals Corporation $4,360,760 49 payments

Who received the money Research payments · program years 2020–2023

Mayo Clinic Jacksonville Organisation paid for research $601,644 2 payments
Austin Institute For Clinical Research Organisation paid for research $531,464 3 payments
Gwinnett Clinical Research Center Organisation paid for research $506,899 3 payments
Oregon Medical Research Center Organisation paid for research $455,946 3 payments
University Of Alabama Hospital Teaching hospital · AL $404,174 2 payments
Clinical Research Center Of The Carolinas Organisation paid for research $297,807 2 payments
Ccd Research Pllc Organisation paid for research $276,605 4 payments
Icahn School Of Medicine At Mount Sinai Department Dermatology Department Attn Yvonne Myers Organisation paid for research $176,841 2 payments
University Of Miami Organisation paid for research $153,277 3 payments
Center For Clinical Studies Organisation paid for research $145,112 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Cite this record

“A Proof of Concept Study to Evaluate the Efficacy, Safety and Tolerability of Secukinumab 300 MG Over 32 Weeks in Adult Patients With Biopsy-Proven Forms of Lichen Planus Not Adequately Controlled With Topical Therapies - Prelude”, Who Paid My Doc, citing CMS Open Payments, program year 2023. https://www.whopaidmydoc.com/research-studies/a-proof-of-concept-study-to-evaluate-the-efficacy-safety-and-tolerability-of-secukinumab-300-mg-over-32-weeks-in-adult-patients-with-biopsy-proven-forms-of-lichen-planus-not-adequately-controlled-with-topical-therapies-prelude-166960425

Figures here may be reproduced with attribution and a link — see for journalists and researchers.